Radiotheranostics Global Market Report 2023

Description

“Radiotheranostics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotheranostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotheranostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The radiotheranostics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; Fludeoxyglucose-18F; Yttrium-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioisotopes
2) By Approach: Targeted Therapeutic; Targeted Diagnostic
3) By Application: Oncology; Non-Oncology
4) By End-Users: Hospitals and Clinics; Pharmaceutical and Biotechnology Companies; Other End-Users
Companies Mentioned: Lantheus Holdings Inc.; Cardinal Health Inc.; GE Healthcare Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the radiotheranostics market are: Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Boston Scientific Corporation, Terumo Corporation, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., and Navidea Biopharmaceuticals Inc.

The global radiotheranostics market is expected to grow from $6.60 billion in 2022 to $7.57 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The radiotheranostics market is expected to reach $12.85 billion in 2027 at a CAGR of 14.1%.

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Radiotheranostics refers to diagnoses and treatments that utilize imaging methods with radioactive substances to pinpoint specific targets in the body. It is used to administer targeted radiation therapy to defined locations, allowing for precise and tailored cancer treatment while minimizing harm to healthy tissues to enhance treatment results and patient care.

North America was the largest region in the radiotheranostics market in 2022. The regions covered in radiotheranostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main radio theranostics radioisotopes are technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that exists naturally at extremely minute levels in the earth's crust but is mostly man-made and is used to scan the skeleton and heart muscle, but it is also utilized to picture the brain, thyroid, and lungs, liver, spleen, kidney, gall bladder, bone marrow, salivary and lachrymal glands, and some specialized medical research. The various approaches are targeted therapeutic and targeted diagnostic that is applied in oncology, and non-oncology. The end users are hospitals and clinics, pharmaceutical and biotechnology companies, and others.

The increasing prevalence of cancer is expected to propel the growth of the radiotheranostics market going forward. Cancer is a condition in which some cells in the body develop uncontrollably and spread to other regions of the body. Radiotheranostics medicines are commonly employed in cancer to offer the ultimate notion of customized medicine by using paired diagnostic and therapeutic radionuclide probes for the selective and targeted detection and treatment of specific (typically cancer) cells, each of which is suited to the patient's underlying condition to enhance treatment efficiency and better clinical output. For instance, according to Cancer Research UK, a UK-based cancer research organization, approximately 18 million new cancer cases were detected in 2020. Further, there would be 28 million new cancer cases globally each year by 2040, a 54.9% increase over 2020, and is predicted to be more prominent in males (60.6% increase) than girls (48.8% increase). Therefore, the increasing prevalence of cancer drives the radiotheranostics market.

Product innovations are a key trend gaining popularity in the radiotheranostics market. Significant companies are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Advanced Cyclotron Systems Inc., a Canada-based company that supplies and services cyclotrons predominantly used for producing medical isotopes, introduced TR-ALPHA for producing alpha-emitting radioisotopes to treat cancer. It is an appropriate solution to the market demand for a low-cost cyclotron capable of producing vast amounts of Astatine-211, one of the most promising alpha-emitting radioisotopes. The TR-ALPHA is also far smaller, less costly, and simpler to run than previous cyclotron models capable of manufacturing alpha-emitting radioisotopes. It is the ideal solution for hospitals, researchers, and institutions interested in running a dedicated cyclotron to efficiently produce enormous amounts of therapeutic alpha-emitting radioisotopes.

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. With the acquisition, Ariceum aims to broaden its portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and to extend its operations in the US. Theranostics Ltd. is a US-based radiopharmaceutical company that offers radio-theranostics.

The countries covered in the radiotheranostics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Product Code: r8363

1. Executive Summary

2. Radiotheranostics Market Characteristics

3. Radiotheranostics Market Trends And Strategies

4. Radiotheranostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Radiotheranostics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Radiotheranostics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Radiotheranostics Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market

6. Radiotheranostics Market Segmentation

6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Technetium-99
Gallium-68
Iodine-131
Iodine-123
Fludeoxyglucose-18F
Yttrium-90
Lutetium (Lu) 177
Copper (Cu) 67
Copper (Cu) 64
Other Radioisotopes
6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Targeted Therapeutic
Targeted Diagnostic
6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oncology
Non-Oncology
6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Other End-Users

7. Radiotheranostics Market Regional And Country Analysis

7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Radiotheranostics Market

8.1. Asia-Pacific Radiotheranostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Radiotheranostics Market

9.1. China Radiotheranostics Market Overview
9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Radiotheranostics Market

10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Radiotheranostics Market

11.1. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Radiotheranostics Market

12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Radiotheranostics Market

13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Radiotheranostics Market

14.1. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Radiotheranostics Market

15.1. Western Europe Radiotheranostics Market Overview
15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Radiotheranostics Market

16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Radiotheranostics Market

17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Radiotheranostics Market

18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Italy Radiotheranostics Market

19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Spain Radiotheranostics Market

20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. Eastern Europe Radiotheranostics Market

21.1. Eastern Europe Radiotheranostics Market Overview
21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. Russia Radiotheranostics Market

22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. North America Radiotheranostics Market

23.1. North America Radiotheranostics Market Overview
23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. USA Radiotheranostics Market

24.1. USA Radiotheranostics Market Overview
24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Canada Radiotheranostics Market

25.1. Canada Radiotheranostics Market Overview
25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. South America Radiotheranostics Market

26.1. South America Radiotheranostics Market Overview
26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Brazil Radiotheranostics Market

27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

28. Middle East Radiotheranostics Market

28.1. Middle East Radiotheranostics Market Overview
28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

29. Africa Radiotheranostics Market

29.1. Africa Radiotheranostics Market Overview
29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

30. Radiotheranostics Market Competitive Landscape And Company Profiles

30.1. Radiotheranostics Market Competitive Landscape
30.2. Radiotheranostics Market Company Profiles
- 30.2.1. Lantheus Holdings Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Cardinal Health Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. GE Healthcare Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Radiotheranostics Market Other Major And Innovative Companies

31.1. Siemens Healthineers
31.2. Boston Scientific Corporation
31.3. Terumo Corporation
31.4. Orano Med
31.5. Curium SAS
31.6. IBA Molecular
31.7. The Eckert & Ziegler Group
31.8. Advanced Accelerator Applications (AAA)
31.9. Telix Pharmaceuticals Limited.
31.10. Abdera Therapeutics
31.11. Blue Earth Diagnostics
31.12. Sirtex Medical Limited
31.13. Y-mAbs Therapeutics Inc.
31.14. ITM Radiopharma
31.15. NorthStar Medical Radioisotopes LLC

32. Global Radiotheranostics Market Competitive Benchmarking

33. Global Radiotheranostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Radiotheranostics Market

35. Radiotheranostics Market Future Outlook and Potential Analysis

35.1 Radiotheranostics Market In 2027 - Countries Offering Most New Opportunities
35.2 Radiotheranostics Market In 2027 - Segments Offering Most New Opportunities
35.3 Radiotheranostics Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer